Bronchial Diseases  >>  ciprofloxacin (Q3939)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ciprofloxacin (Q3939) / Bayer, Novartis
NCT02661438: Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation Using Placebo

Completed
N/A
46
US
Placebo to Ciprofloxacin DPI (BAYQ3939)
Bayer, Novartis
Bronchiectasis, Pulmonary Disease, Chronic Obstructive
03/16
03/16

Download Options